1-7 of 7
Jiazhuo Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Orelabrutinib-Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Treatment of Marginal Zone Lymphoma: A Retrospective Study

He LI, Jiazhuo Liu, Yuhui Chen, Pazilaiti Tuohuti, Yutong Wang, Xinzhu Tang, Bing Xiang, Yongqian Jia, Yu Wu, Yun Tang, Yong Guo, Jie Wang, Yuhuan Zheng, Yu Liu, Ting Niu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6308.
https://doi.org/10.1182/blood-2024-206464
Published: 2024
Journal Articles

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Clinical Trials & Observations
Pengpeng Liu, Xiangyu Pan, Chong Chen, Ting Niu, Xiao Shuai, Jian Wang, Xuelan Chen, Jiazhuo Liu, Yong Guo, Liping Xie, Yu Wu, Yu Liu, Ting Liu
Journal: Blood
Blood (2020) 135 (11): 826–833.
https://doi.org/10.1182/blood.2019003886
Published: 2020
Includes: Supplemental data
Journal Articles

Chidamide-Containing Conditioning Allogenic Hematopoietic Stem Cell Transplantation Improves Prognosis of Acute Lymphoblastic Leukemia with Pre-Transplant Response Less Than Complete Remission

Jie Ji, MD, Tian Dong, MD PhD, Pu Kuang, MD PhD, Zhigang Liu, MD, Jiazhuo Liu, MD PhD, Li Zhang, MD, Ting Niu, MD PhD, Ting Liu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3366.
https://doi.org/10.1182/blood-2018-99-114763
Published: 2018
Journal Articles

Chidamide, a HDAC Inhibitor, Combined with Cladribine, High Dose Gemcitabine and Busulfan with Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory and Poor-Risk Lymphoma

Jie Ji, MD, Ting Liu, MDPhD, Pu Kuang, MD PhD, Zhigang Liu, MD, Tian Dong, MD PhD, Jiazhuo Liu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3288.
https://doi.org/10.1182/blood.V130.Suppl_1.3288.3288
Published: 2017
Journal Articles

Pilot Study of Safety and Efficacy of Chidamide in Allogenic Peripheral Hematopoietic Stem Cell Transplantation: Better Disease Control and Positively Lower Graft Versus Host Disease

Jie Ji, MD, Ting Liu, MDPhD, Pu Kuang, MD PhD, Zhigang Liu, MD, Tian Dong, MD PhD, Jiazhuo Liu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4583.
https://doi.org/10.1182/blood.V130.Suppl_1.4583.4583
Published: 2017
Journal Articles

Sirolimus Combined with Dexamethasone for the Treatment of a Patient with Interferon Resistant Hydroa Vacciniform-Like Lymphoma

Zhigang Liu, MD, Yongqian Jia, MD, Yuping Gong, MD, PhD, Yong Guo, MD, Jiazhuo Liu, MD, Ting Liu, MD
Journal: Blood
Blood (2011) 118 (21): 4992.
https://doi.org/10.1182/blood.V118.21.4992.4992
Published: 2011
Journal Articles

Intensified Induction Chemotherapy with Regimen Containing Intermediate Dose Cytarabine for De Novo Acute Myeloid Leukemia.

Jianxiang Wang, M.D., Yingchang Mi, M.D., Ph.D., Jiazhuo Liu, Mingwei Fu, Ying Wang, Dong Lin, Shougeng Bian
Journal: Blood
Blood (2008) 112 (11): 943.
https://doi.org/10.1182/blood.V112.11.943.943
Published: 2008